AFL:NYE-Aflac Incorporated (USD)

COMMON STOCK | Insurance - Life |

Last Closing

USD 107.92

Change

0.00 (0.00)%

Market Cap

USD 60.44B

Volume

8.45M

Analyst Target

USD 41.11
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia. Address: 1932 Wynnton Road, Columbus, GA, United States, 31999

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

ETFs Containing AFL

BFIN:CA Brompton North American F.. 5.37 % 0.96 %

N/A

CAD 0.05B
CWS AdvisorShares Focused Equ.. 4.69 % 0.68 %

N/A

USD 0.17B
DIVS SmartETFs Dividend Builde.. 3.23 % 0.00 %

N/A

USD 0.03B
SHRY First Trust Bloomberg Sha.. 3.02 % 0.00 %

N/A

USD 0.02B
CCOR Core Alternative ETF 2.99 % 1.23 %

N/A

USD 0.13B
BDIV:CA Brompton Global Dividend .. 2.91 % 0.96 %

N/A

CAD 0.09B
FTDS First Trust Dividend Stre.. 2.29 % 0.00 %

N/A

USD 0.02B
FCSG:LSE FIRST TRUST GLOBAL FUNDS .. 2.24 % 0.00 %

N/A

USD 0.03B
RDVY First Trust Rising Divide.. 2.23 % 0.50 %

N/A

USD 11.98B
FTCS First Trust Capital Stren.. 2.22 % 0.60 %

N/A

USD 9.02B
FTCS:LSE First Trust Capital Stren.. 2.18 % 0.00 %

N/A

USD 9.99M
CESG:LSE FIRST TRUST GLOBAL FUNDS .. 2.07 % 0.00 %

N/A

N/A
KNG 1.66 % 0.00 %

N/A

N/A
SYLD 1.28 % 0.59 %

N/A

N/A
LSAF LeaderSharesTM AlphaFacto.. 1.15 % 0.75 %

N/A

USD 0.15B
JKI 1.03 % 0.30 %

N/A

N/A
PAPI Morgan Stanley ETF Trust 0.67 % 0.00 %

N/A

USD 0.04B
2B77:XETRA iShares Ageing Population.. 0.61 % 0.00 %

N/A

USD 0.50B
2B77:F iShares Ageing Population.. 0.61 % 0.00 %

N/A

N/A
JPME JPMorgan Diversified Retu.. 0.46 % 0.24 %

N/A

USD 0.41B
XZEW:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

N/A

USD 1.56B
XEWE:XETRA Xtrackers S&P 500 Equal W.. 0.41 % 0.00 %

N/A

USD 1.53B
QUS:AU BetaShares S&P 500 Equal .. 0.25 % 0.00 %

N/A

USD 0.44B
CORP PIMCO Investment Grade Co.. 0.00 % 0.20 %

N/A

USD 1.27B
FHF:CA 0.00 % 0.77 %

N/A

N/A
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

N/A

CAD 0.09B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IAK iShares U.S. Insurance ET.. 0.00 % 0.43 %

N/A

N/A
IWR iShares Russell Mid-Cap E.. 0.00 % 0.19 %

N/A

USD 36.20B
PHE.B:CA 0.00 % 0.97 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
CLRG 0.00 % 0.25 %

N/A

N/A
TPHD Timothy Plan High Dividen.. 0.00 % 0.00 %

N/A

USD 0.23B
DBX4:F Xtrackers - MSCI EM Europ.. 0.00 % 0.00 %

N/A

N/A
VLIQ:XETRA 0.00 % 0.00 %

N/A

N/A
NSGE:CA NBI Sustainable Global Eq.. 0.00 % 0.00 %

N/A

CAD 0.53B
JOET Virtus ETF Trust II 0.00 % 0.00 %

N/A

USD 0.12B
VDLQ:LSE 0.00 % 0.00 %

N/A

N/A
IMCV iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

USD 0.64B
ADIV SmartETFs Asia Pacific Di.. 0.00 % 0.00 %

N/A

USD 4.28M
IMCB iShares Morningstar Mid-C.. 0.00 % 0.00 %

N/A

USD 0.99B
QDIV Global X S&P 500® Qualit.. 0.00 % 0.00 %

N/A

USD 0.03B
TPHE Timothy Plan - Timothy Pl.. 0.00 % 0.00 %

N/A

USD 0.07B
FTGS:XETRA FIRST TRUST GLOBAL FUNDS .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Insurance - Life) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 30.81% 94% A 91% A-
Dividend Return 1.82% 31% F 40% F
Total Return 32.63% 89% A- 91% A-
Trailing 12 Months  
Capital Gain 41.42% 78% C+ 87% B+
Dividend Return 2.52% 31% F 38% F
Total Return 43.94% 78% C+ 87% B+
Trailing 5 Years  
Capital Gain 106.15% 87% B+ 87% B+
Dividend Return 14.31% 25% F 53% F
Total Return 120.46% 87% B+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 20.44% 78% C+ 83% B
Dividend Return 23.15% 83% B 84% B
Total Return 2.71% 38% F 56% F
Risk Return Profile  
Volatility (Standard Deviation) 23.13% 67% D+ 45% F
Risk Adjusted Return 100.10% 100% F 97% N/A
Market Capitalization 60.44B 100% F 96% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector